Clinical trial
Nicotinic Acid - Pharmacokinetics, Pharmacodynamics, Receptor Expression
NCT00176020 · Heidelberg University, Other · Unknown status
Key facts
| NCT number | NCT00176020 |
|---|---|
| Title | Nicotinic Acid - Pharmacokinetics, Pharmacodynamics, Receptor Expression |
| Official title | Double-Blind, Randomized, Placebo-Controlled, Single-Center, 2 Treatment, 3-Way Crossover Study to Investigate the Pharmacodynamics, Pharmacokinetics and Safety of a Single Oral Repeated Dose of 500 Mg Nicotinic Acid as Tablets in Healthy Subjects |
| Lead sponsor | Heidelberg University, Other |
| Status | Unknown status |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Healthy |
| Intervention type | Drug |
| Interventions | nicotinic acid |
| Enrollment | 18 |
| First posted | Sep 15, 2005 |
| Last update posted | Mar 15, 2006 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: